Complications of Diabetes: Neuropathy Screening and Management

About

Diabetic neuropathy is a common and progressive manifestation of diabetes complications in India, driven by chronic metabolic, inflammatory, and microvascular injury to peripheral and autonomic nerves. Its development is closely related to disease duration, cumulative glycemic exposure, and the presence of cardiometabolic risk factors such as dyslipidemia and hypertension. Clinically, this condition contributes to a substantial symptom burden, including chronic pain, sensory loss, impaired balance, and reduced functional capacity, with downstream effects on mobility and quality of life.

The spectrum of neuropathic syndromes encompasses multiple clinical phenotypes with overlapping and distinct features. Diabetic peripheral neuropathy is typically characterized by length-dependent sensory loss, neuropathic pain, paresthesia, and, in advanced stages, motor weakness and muscle atrophy. In contrast, diabetic autonomic neuropathy involves dysfunction of cardiovascular, gastrointestinal, genitourinary, and sudomotor systems, often presenting insidiously and carrying an increased risk of morbidity and mortality. Treatment induced neuropathy of diabetes, a less typical acute neuropathic syndrome, is associated with rapid improvement in glycemic control and presents with severe pain and autonomic symptoms over a distinct temporal course.

Clinical features and diagnostic considerations include careful assessment of symptom patterns, detailed neurologic examination findings, and the use of commonly applied screening tools in routine practice. Sensory testing, reflex assessment, and evaluation of autonomic function are central to clinical recognition.

Core principles of diabetes neuropathy management integrate optimization of metabolic control with targeted pharmacologic strategies for neuropathic pain. These approaches are complemented by nonpharmacologic and supportive interventions, including patient education, foot care, physical activity, and measures aimed at preserving function and preventing secondary injury. Individualization of therapy is emphasized due to variability in symptom severity, comorbidities, and treatment tolerance.

Overall, this lecture emphasizes the progressive nature of diabetic neuropathy and its central role in amplifying long-term diabetes complications, including foot ulceration, falls, and cardiovascular risk. Ongoing surveillance and coordinated care are highlighted as essential components in limiting neurologic progression and systemic sequelae.